Angiotech to participate in Bank of America 2007 Credit Conference
27 November 2007 - 10:00PM
PR Newswire (US)
VANCOUVER, Nov. 27 /PRNewswire-FirstCall/ -- Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), a global
specialty pharmaceutical and medical device company, is scheduled
to participate in the Bank of America 2007 Credit Conference, which
is being held December 2 - 4 in Orlando, FL. Tom Bailey, Angiotech
Chief Financial Officer, will give a 15-minute formal presentation
followed by a 25-minute Question and Answer period on Monday,
December 3, beginning at approximately 8:30am ET. A live webcast of
Mr. Bailey's remarks will be available to all interested parties at
Angiotech's website, http://www.angiotech.com/, in the Investors
section. To ensure a timely connection to the webcast it is
recommended that users register at least 15 minutes before the
webcast begins. The webcast will be archived approximately one hour
after the conclusion of the live event and will be available until
December 21, 2007. About Angiotech Angiotech Pharmaceuticals, Inc.
is a global specialty pharmaceutical and medical device company
with over 1,500 dedicated employees. Angiotech discovers, develops
and markets innovative treatment solutions for diseases or
complications associated with medical device implants, surgical
interventions and acute injury. To find out more about Angiotech
(NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please visit our website at
http://www.angiotech.com/. CONTACT: Deirdre Neary, Manager,
Investor Relations, Angiotech Pharmaceuticals, Inc., (604)
222-7056, DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT:
Deirdre Neary, Manager, Investor Relations, Angiotech
Pharmaceuticals, Inc., (604) 222-7056,
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals - Common Shares (MM) News-Artikel